The General Pharmaceutical Council
Duncan Rudkin, chief executive of the General Pharmaceutical Council (GPhC), will step down from his role on 31 December 2025, the regulator has announced.
On 30 July 2025, the GPhC said that it is “committed to ensuring a smooth transition” after a new chief executive and registrar is recruited.
Rudkin, who has been in post since the GPhC was established in 2010, said the role has been “a great privilege”.
“I am proud of the work the team have done to uphold standards of care and quality in pharmacy services, and to put patient safety at the heart of everything we do,” he said.
“With a strong new strategic plan in place, now is the right time for me to step down and support a successful transition to a new chief executive and registrar.”
Gisela Abbam, chair of the GPhC, thanked Rudkin for his “significant” and “invaluable” contribution to pharmacy regulation, including his focus on patient safety.
“As Duncan embarks on new ventures, we are presented with a unique opportunity to welcome a new chief executive and registrar who will champion the next phase of our journey. This transition is a pivotal moment for the GPhC, as we look to implement our ambitious five-year strategy,” she added.
The GPhC strategic plan for 2025–2030 outlines its priorities to strengthen public trust, regulatory performance and support for the pharmacy profession.
